Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
6.83
Price to sales ratio
6.83

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1961
ADMA
ADMA Biologics Inc - Common Stock
8.97 USD-1.21%-3.34%+8.60%-51.93%2.08 B USD
1963
MESO
Mesoblast Limited - American Depositary Shares
16.22 USD+5.05%+12.64%+16.77%+44.95%2.08 B USD
1966
HRMY
Harmony Biosciences Holdings, Inc. - Common Stock
35.54 USD-3.53%-5.07%+3.95%+15.02%2.06 B USD
1977
ANAB
AnaptysBio, Inc. - Common Stock
69.81 USD+5.15%+12.18%+23.25%+98.32%2.03 B USD

Frequently asked questions about Aurinia Pharmaceuticals Inc - Common Shares

What is the Aurinia Pharmaceuticals Inc - Common Shares stock price today?

The current price of Aurinia Pharmaceuticals Inc - Common Shares (AUPH) is 16.03. Over the past 24 hours, the stock has changed by +1.58%. Follow the AUPH chart for real-time price dynamics.

What is the stock ticker of Aurinia Pharmaceuticals Inc - Common Shares?

Aurinia Pharmaceuticals Inc - Common Shares trades under the ticker AUPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Aurinia Pharmaceuticals Inc - Common Shares stock going up?

AUPH has changed by +3.42% over the last week, +0.63% over the last month, and +34.37% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Aurinia Pharmaceuticals Inc - Common Shares net income for the last quarter?

Aurinia Pharmaceuticals Inc - Common Shares reported net income of 34.35 M for the last quarter. The previous quarter showed 210.79 M, which means net income changed by -83.70%.

How many employees does Aurinia Pharmaceuticals Inc - Common Shares have?

As of the latest available data, Aurinia Pharmaceuticals Inc - Common Shares has 128 employees. Workforce size can provide additional context about the company's scale and operations.

What is Aurinia Pharmaceuticals Inc - Common Shares EBITDA?

Aurinia Pharmaceuticals Inc - Common Shares EBITDA is 46.24 M, and its EBITDA margin is 59.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Aurinia Pharmaceuticals Inc - Common Shares stock?

You can buy Aurinia Pharmaceuticals Inc - Common Shares (AUPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Aurinia Pharmaceuticals Inc - Common Shares stock?

Investing in Aurinia Pharmaceuticals Inc - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AUPH chart and related analysis on metatrader.com as part of your research.

News